Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;260(10):2523-31.
doi: 10.1007/s00415-013-7011-2. Epub 2013 Jun 29.

Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease

Tobias Böttcher  1 , Arndt Rolfs, Bianca Meyer, Annette Grossmann, Daniela Berg, Peter Kropp, Reiner Benecke, Uwe Walter
Affiliations

Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease

Tobias Böttcher et al. J Neurol. 2013 Oct.

Abstract

Homozygous or compound heterozygous mutations in the glucocerebrosidase gene cause Gaucher disease. Moreover, heterozygous glucocerebrosidase gene mutations represent the most common genetic risk factor for Parkinson's disease (PD) known so far. Substantia nigra (SN) hyperechogenicity, a sonographic feature thought to reflect iron accumulation, has been described in both PD and Gaucher disease patients. Here we studied how clinical, genetic, and brain sonographic findings relate to the occurrence of PD in Gaucher disease. Sixteen Gaucher disease patients, 12 PD patients, and 32 control subjects were enrolled. The glucocerebrosidase genotypes were identified by DNA sequencing. All subjects underwent transcranial ultrasound, and eight Gaucher disease patients additionally MRI for comparison with SN ultrasound findings. SN hyperechogenicity and reduced echogenicity of brainstem raphe were more frequent in Gaucher disease patients (62, 37 %) than in controls (12, 12 %; p < 0.001, p < 0.05). SN hyperechogenicity in Gaucher disease patients was unrelated to type or severity of glucocerebrosidase gene mutation, but correlated with iron-sensitive MRI-T2 hypointensity of SN pars compacta, and with age at start of enzyme replacement therapy. While none of the five Gaucher disease patients with signs of PD (definite PD, n = 4; early PD, n = 1) had severe glucocerebrosidase gene mutations known to cause neuronopathic Gaucher disease, all carried a N370S allele, previously reported to predict non-neuronopathic Gaucher disease. Hyposmia, higher non-motor symptoms score (constipation, depression, executive dysfunction), and SN hyperechogenicity were characteristic features of Gaucher disease-related PD. We conclude that the combined clinical, genetic, and transcranial sonographic assessment may improve the PD risk evaluation in Gaucher disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
    1. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):441-7 - PubMed
    1. Mov Disord. 2010 Jul 30;25(10):1364-72 - PubMed
    1. Mol Genet Metab. 2003 Jun;79(2):104-9 - PubMed
    1. J Inherit Metab Dis. 2010 Apr;33(2):167-73 - PubMed

MeSH terms

Substances

LinkOut - more resources